UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM
Report
- Report Number
- 2122870-2007-00023
- Event Type
- Other
- Date Received
- January 29, 2007
- Date of Event
- January 5, 2007
- Report Date
- January 29, 2007
- Manufacturer
- BECKMAN COULTER, INC.
- Product Code
- JJE
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- NO INFORMATION
Narratives
QC AND SYSTEM CHECK INFO HAVE NOT BEEN PROVIDED. THE SPECIMEN WAS COLLECTED IN BD, LITHIUM HEPARIN TUBE WITHOUT GEL SEPARATORS. A FIELD SVC ENGINEER (FSE) WAS DISPATCHED TO THE CUSTOMER'S LAB. THE FSE PERFORMED DIAGNOSTIC AND PRECISION TESTING, AND CONDUCTED PIPETTOR VERIFICATIONS; ALL RESULTS PASSED WITHIN SPECS. THE FSE HAD BIO-MEDICAL ENGINEER VERIFY CENTRIFUGE SPEED WHICH MET SPECS. THE BECKMAN COULTER INC. (BCI) APPLICATIONS SPECIALIST (AS) REVIEWED WITH THE CUSTOMER PRE-ANALYTICAL SAMPLE HANDLING PROCESS. THE CUSTOMER IS CONSIDERING USING SEPARATOR TUBES AND/OR FILTERS IN THE FUTURE. ALTHOUGH PRE-ANALYTICAL FACTORS MAY HAVE CONTRIBUTED TO THIS EVENT, A CLEAR ROOT CAUSE HAS NOT BEEN DETERMINED IN THIS EVENT. A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.
A CUSTOMER CONTACTED BECKMAN COULTER REGARDING AN ERRONEOUSLY HIGH TROPONIN (ACCU TNI) RESULT FROM A SINGLE PT SAMPLE THAT WAS GENERATED BY THE UNICEL DXI 800 ACCESS INSTRUMENT. A PT SAMPLE WAS TESTED FOR ACCU TNI AND A RESULT OF 0.55NG/ML WAS OBTAINED. THE RESULT WAS REPORTED OUT OF THE LAB AND QUESTIONED BY A PHYSICIAN. THE ORIGINAL SAMPLE WAS RETESTED ON THE SAME DAY, AND THE REPEATED ACCU TNI RESULT WAS 0.04NG/ML. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PT TREATMENT THAT CAN BE ATTRIBUTED TO OR CONNECTED WITH THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM | DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER | JJE | BECKMAN COULTER, INC. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA |